Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' Meco, G' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 47 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Bonifati, V; De Michele, G; Lucking, CB; Durr, A; Fabrizio, E; Ambrosio, G; Vanacore, N; De Mari, M; Marconi, R; Capus, L; Breteler, MMB; Gasser, T; Oostra, B; Wood, N; Agid, Y; Filla, A; Meco, G; Brice, A
      The parkin gene and its phenotype

      NEUROLOGICAL SCIENCES
    2. Vanacore, N; Bonifati, V; Fabbrini, G; Colosimo, C; De Michele, G; Marconi, R; Nicholl, D; Locuratolo, N; Talarico, G; Romano, S; Stocchi, F; Bonuccelli, U; De Mari, M; Vieregge, P; Meco, G
      Epidemiology of multiple system atrophy

      NEUROLOGICAL SCIENCES
    3. Vanacore, N; Bonifati, V; Colosimo, C; Fabbrini, G; De Michele, G; Marconi, R; Nicholl, D; Locuratolo, N; Romano, S; Talarico, G; Stocchi, F; Bonuccelli, U; Lamberti, P; Vieregge, P; Meco, G
      Epidemiology of progressive supranuclear palsy

      NEUROLOGICAL SCIENCES
    4. Gasparini, M; Bonifati, V; Fabrizio, E; Fabbrini, G; Brusa, L; Lenzi, GL; Meco, G
      Frontal lobe dysfunction in essential tremor - A preliminary study

      JOURNAL OF NEUROLOGY
    5. Lucking, CB; Bonifati, V; Periquet, M; Vanacore, N; Brice, A; Meco, G
      Pseudo-dominant inheritance and exon 2 triplication in a family with parkin gene mutations

      NEUROLOGY
    6. Casali, C; Bonifati, V; Santorelli, FM; Casari, G; Fortini, D; Patrignani, A; Fabbrini, G; Carrozzo, R; D'Amati, G; Locuratolo, N; Vanacore, N; Damiano, M; Pierallini, A; Pierelli, F; Amabile, GA; Meco, G
      Mitochondrial myopathy, parkinsonism, and multiple mtDNA deletions in a sephardic Jewish family

      NEUROLOGY
    7. Bonifati, V; Lucking, CB; Fabrizio, E; Periquet, M; Meco, G; Brice, A
      Three parkin gene mutations in a sibship with autosomal recessive early onset parkinsonism

      JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
    8. Periquet, M; Lucking, CB; Vaughan, JR; Bonifati, V; Durr, A; De Michele, G; Horstink, MW; Farrer, M; Illarioshkin, SN; Pollak, P; Borg, M; Brefel-Courbon, C; Denefle, P; Meco, G; Gasser, T; Breteler, MMB; Wood, NW; Agid, Y; Brice, A
      Origin of the mutations in the parkin gene in europe: Exon rearrangements are independent recurrent events, whereas point mutations may result from founder effects

      AMERICAN JOURNAL OF HUMAN GENETICS
    9. Colosimo, C; Vanacore, N; Bonifati, V; Fabbrini, G; Rum, A; De Michele, G; De Mari, M; Bonuccelli, U; Nicholl, DJ; Meco, G
      Clinical diagnosis of multiple system atrophy: level of agreement between Quinn's criteria and the consensus conference guidelines

      ACTA NEUROLOGICA SCANDINAVICA
    10. Fabbrini, G; Barbanti, P; Bonifati, V; Colosimo, C; Gasparini, M; Vanacore, N; Meco, G
      Donepezil in the treatment of progressive supranuclear palsy

      ACTA NEUROLOGICA SCANDINAVICA
    11. Vanacore, N; Gasparini, M; Brusa, L; Meco, G
      A possible association between exposure to n-hexane and parkinsonism

      NEUROLOGICAL SCIENCES
    12. Meco, G; Vanacore, N; Locuratolo, N; Bonifati, V; Vella, C; Giovani, A; Tubani, L; Baratta, L; Mastrocola, C
      Heart rate variability in Parkinson's disease patients treated with tolcapone

      PARKINSONISM & RELATED DISORDERS
    13. Meco, G; Alessandri, A
      Can COMT inhibitors improve cognitive functions in patients with Parkinson's disease?

      CNS DRUGS
    14. Barbanti, P; Fabbrini, G; Vanacore, N; Rum, A; Lenzi, G; Meco, G; Cerbo, R
      Dopamine and migraine: does Parkinson's disease modify migraine course?

      CEPHALALGIA
    15. Lucking, CB; Durr, A; Bonifati, V; Vaughan, J; De Michele, G; Gasser, T; Harhangi, BS; Meco, G; Denefle, P; Wood, NW; Agid, Y; Brice, A
      Association between early-onset Parkinson's disease and mutations in the parkin gene

      NEW ENGLAND JOURNAL OF MEDICINE
    16. Vanacore, N; Bonifati, V; Fabbrini, G; Colosimo, C; Marconi, R; Nicholl, D; Bonuccelli, U; Stocchi, F; Lamberti, P; Volpe, G; De Michele, G; Iavarone, I; Bennett, P; Vieregge, P; Meco, G
      Smoking habits in multiple system atrophy and progressive supranuclear palsy

      NEUROLOGY
    17. Abbas, N; Lucking, CB; Ricard, S; Durr, A; Bonifati, V; De Michele, G; Bouley, S; Vaughan, JR; Gasser, T; Marconi, R; Broussolle, E; Brefel-Courbon, C; Harhangi, BS; Oostra, AB; Fabrizio, E; Bohme, GA; Pradier, L; Wood, NW; Filla, A; Meco, G; Denefle, P; Agid, Y; Brice, A
      A wide variety of mutations in the parkin gene are responsible for autosomal recessive parkinsonism in Europe

      HUMAN MOLECULAR GENETICS
    18. Barbanti, P; Fabbrini, G; Ricci, A; Cerbo, R; Bronzetti, E; Caronti, B; Calderaro, C; Felici, L; Stocchi, F; Meco, G; Amenta, F; Lenzi, GL
      Increased expression of dopamine receptors on lymphocytes in Parkinson's disease

      MOVEMENT DISORDERS
    19. Bonifati, V; Joosse, M; Nicholl, DJ; Vanacore, N; Bennett, P; Rizzu, P; Fabbrini, G; Marconi, R; Colosimo, C; Locuratolo, N; Stocchi, F; Bonuccelli, U; De Mari, M; Wenning, G; Vieregge, P; Oostra, B; Meco, G; Heutink, P
      The tau gene in progressive supranuclear palsy: exclusion of mutations in coding exons and exon 10 splice sites, and identification of a new intronicvariant of the disease-associated H1 haplotype in Italian cases

      NEUROSCIENCE LETTERS
    20. Harhangi, BS; Farrer, MJ; Lincoln, S; Bonifati, V; Meco, G; De Michele, G; Brice, A; Durr, A; Martinez, M; Gasser, T; Bereznai, B; Vaughan, JR; Wood, NW; Hardy, J; Oostra, BA; Breteler, MMB
      The lle93Met mutation in the ubiquitin carboxy-terminal-hydrolase-L1 gene is not observed in European cases with familial Parkinson's disease

      NEUROSCIENCE LETTERS
    21. Bonifati, V; Meco, G
      New, selective catechol-O-methyltransferase inhibitors as therapeutic agents in Parkinson's disease

      PHARMACOLOGY & THERAPEUTICS
    22. Nicholl, DJ; Bennett, P; Hiller, L; Bonifati, V; Vanacore, N; Fabbrini, G; Marconi, R; Colosimo, C; Lamberti, P; Stocchi, F; Bonuccelli, U; Vieregge, P; Ramsden, DB; Meco, G; Williams, AC
      A study of five candidate genes in Parkinson's disease and related neurodegenerative disorders

      NEUROLOGY
    23. Vanacore, N; Spila-Alegiani, S; Raschetti, R; Meco, G
      Mortality cancer risk in parkinsonian patients: A population-based study -Reply

      NEUROLOGY
    24. Vanacore, N; Spila-Alegiani, S; Raschetti, R; Meco, G
      Mortality cancer risk in parkinsonian patients: A population-based study

      NEUROLOGY
    25. Mastrocola, C; Vanacore, N; Giovani, A; Locuratolo, N; Vella, C; Alessandri, A; Baratta, L; Tubani, L; Meco, G
      Twenty-four-hour heart rate variability to assess autonomic function in Parkinson's disease

      ACTA NEUROLOGICA SCANDINAVICA
    26. VAUGHAN JR; FARRER MJ; WSZOLEK ZK; GASSER T; DURR A; AGID Y; BONIFATI V; DEMICHELE G; VOLPE G; LINCOLN S; BRETELER M; MECO G; BRICE A; MARSDEN CD; HARDY J; WOOD NW
      SEQUENCING OF THE ALPHA-SYNUCLEIN GENE IN A LARGE SERIES OF CASES OF FAMILIAL PARKINSONS-DISEASE FAILS TO REVEAL ANY FURTHER MUTATIONS

      Human molecular genetics
    27. BARBANTI P; FABBRINI G; VANACORE N; PASCALI MP; RUM A; MECO G; LENZI GL; CERBO R
      DOPAMINE AND MIGRAINE - DOES PARKINSONS-DISEASE MODIFY THE COURSE OF MIGRAINE

      Annals of neurology
    28. VAUGHAN J; DURR A; TASSIN J; BEREZNAI B; GASSER T; BONIFATI V; DEMICHELE G; FABRIZIO E; VOLPE G; BANDMANN O; JOHNSON WG; GOLBE LI; BRETELER M; MECO G; AGID Y; BRICE A; MARSDEN CD; WOOD NW
      THE ALPHA-SYNUCLEIN ALA53THR MUTATION IS NOT A COMMON-CAUSE OF FAMILIAL PARKINSONS-DISEASE - A STUDY OF 230 EUROPEAN CASES

      Annals of neurology
    29. BENNETT P; BONIFATI V; BONUCCELLI U; COLOSIMO C; DEMARI M; FABBRINI G; MARCONI R; MECO G; NICHOLL DJ; STOCCHI F; VANACORE N; VIEREGGE P; WILLIAMS AC
      DIRECT GENETIC-EVIDENCE FOR INVOLVEMENT OF TAU IN PROGRESSIVE SUPRANUCLEAR PALSY

      Neurology
    30. MECO G; FABRIZIO E; ALESSANDRI A; VANACORE N; BONIFATI V
      RISPERIDONE IN LEVODOPA-INDUCED DYSKINESIAE

      Journal of Neurology, Neurosurgery and Psychiatry
    31. FABBRINI G; VANACORE N; BONIFATI V; COLOSIMO C; MECO G
      PRESYMPTOMATIC HYPERTENSION IN PROGRESSIVE SUPRANUCLEAR PALSY

      Archives of neurology
    32. TASSIN J; DURR A; DEBROUCKER T; ABBAS N; BONIFATI V; DEMICHELE G; BONNET AM; BROUSSOLLE E; POLLAK P; VIDAILHET M; DEMARI M; MARCONI R; MEDJBEUR S; FILLA A; MECO G; AGID Y; BRICE A
      CHROMOSOME 6-LINKED AUTOSOMAL RECESSIVE EARLY-ONSET PARKINSONISM - LINKAGE IN EUROPEAN AND ALGERIAN FAMILIES, EXTENSION OF THE CLINICAL SPECTRUM, AND EVIDENCE OF A SMALL HOMOZYGOUS DELETION IN ONE FAMILY

      American journal of human genetics
    33. RASCHETTI R; SPILAALEGIANI S; VANACORE N; ANCONA C; MECO G
      MORTALITY IN A POPULATION-BASED COHORT OF PATIENTS TREATED WITH ANTIPARKINSONIAN DRUGS

      Acta neurologica Scandinavica
    34. MARGOTTA V; CARONTI B; MECO G; MERANTE A; RUGGIERI S; VENTURINI G; PALLADINI G
      EFFECTS OF COCAINE TREATMENT ON THE NERVOUS-SYSTEM OF PLANARIA (DUGESIA-GONOCEPHALA S.L.) - HISTOCHEMICAL AND ULTRASTRUCTURAL OBSERVATIONS

      European journal of histochemistry
    35. MECO G; ALESSANDRI A; GIUSTINI P; BONIFATI V
      RISPERIDONE IN LEVODOPA-INDUCED PSYCHOSIS IN ADVANCED PARKINSONS-DISEASE - AN OPEN-LABEL, LONG-TERM STUDY

      Movement disorders
    36. GASPARINI M; FABRIZIO E; BONIFATI V; MECO G
      COGNITIVE IMPROVEMENT DURING TOLCAPONE TREATMENT IN PARKINSONS-DISEASE

      Journal of neural transmission
    37. GASSER T; MULLERMYHSOK B; WSZOLEK ZK; DURR A; VAUGHAN JR; BONIFATI V; MECO G; BEREZNAI B; OEHLMANN R; AGID Y; BRICE A; WOOD N
      GENETIC COMPLEXITY AND PARKINSONS-DISEASE

      Science
    38. MECO G; GASPARINI M; DORICCHI F
      ATTENTIONAL FUNCTIONS IN MULTIPLE SYSTEM ATROPHY AND PARKINSONS-DISEASE

      Journal of Neurology, Neurosurgery and Psychiatry
    39. MECO G; BONIFATI V; ALESSANDRI A; BRUSA L
      RISPERIDONE IN HUNTINGTONS-DISEASE

      Human psychopharmacology
    40. BONIFATI V; FABRIZIO E; VANACORE N; DEMARI M; MECO G
      FAMILIAL PARKINSONS-DISEASE - A CLINICAL GENETIC-ANALYSIS

      Canadian journal of neurological sciences
    41. MENNITIIPPOLITO F; SPILAALEGIANI S; VANACORE N; BONIFATI V; DIANI G; MECO G; RASCHETTI R
      ESTIMATE OF PARKINSONISM PREVALENCE THROUGH DRUG PRESCRIPTION HISTORIES IN THE PROVINCE OF ROME, ITALY

      Acta neurologica Scandinavica
    42. MECO G; BONIFATI V; FABRIZIO E; VANACORE N
      WORSENING OF PARKINSONISM WITH FLUVOXAMINE - 2 CASES

      Human psychopharmacology
    43. BONIFATI V; FABRIZIO E; CIPRIANI R; VANACORE N; MECO G
      BUSPIRONE IN LEVODOPA-INDUCED DYSKINESIAS

      Clinical neuropharmacology
    44. MECO G; BONIFATI V; VANACORE N; FABRIZIO E
      PARKINSONISM AFTER CHRONIC EXPOSURE TO THE FUNGICIDE MANEB (MANGANESEETHYLENE-BIS-DITHIOCARBAMATE)

      Scandinavian journal of work, environment & health
    45. MECO G; VANACORE N; BONIFATI V
      THE MORTALITY-RATES FOR MULTIPLE-SCLEROSIS IN ITALY (1969-1987)

      Neuroepidemiology
    46. MECO G; ALESSANDRIA A; BONIFATI V; GIUSTINI P
      RISPERIDONE FOR HALLUCINATIONS IN LEVODOPA-TREATED PARKINSONS-DISEASEPATIENTS

      Lancet
    47. BONIFATI V; VANACORE N; MECO G
      ANTICIPATION OF ONSET AGE IN FAMILIAL PARKINSONS-DISEASE

      Neurology


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 15/01/21 alle ore 23:06:10